In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

Lobbezoo D. J. A.; van Kampen R. J. W.; Voogd A. C.; Dercksen M. W.; van den Berkmortel F.; Smilde T. J.; van de Wouw A. J.; Peters F. P. J.; van Riel J. M. G. H.; Peters N. A. J. B.; de Boer M.; Peer P. G. M.; Tjan-Heijnen V. C. G.

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

【24h】

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

机译：在现实生活中，四分之一的激素受体阳性转移性乳腺癌患者接受化疗作为最初的姑息治疗：对东南荷兰乳腺癌协会的一项研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The objective of this study was to present initial systemic treatment choices and the outcome of hormone receptor-positive (HR+) metastatic breast cancer.

机译：背景：本研究的目的是介绍最初的全身治疗选择和激素受体阳性（HR +）转移性乳腺癌的结局。

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2016年第2期|共8页
作者
Lobbezoo D. J. A.; van Kampen R. J. W.; Voogd A. C.; Dercksen M. W.; van den Berkmortel F.; Smilde T. J.; van de Wouw A. J.; Peters F. P. J.; van Riel J. M. G. H.; Peters N. A. J. B.; de Boer M.; Peer P. G. M.; Tjan-Heijnen V. C. G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
metastatic breast cancer; chemotherapy; endocrine therapy; outcome; hormone receptor;

机译：转移性乳腺癌;化学疗法;内分泌疗法;结果;激素受体;

相似文献

外文文献
中文文献
专利

1. In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium [J] . Lobbezoo D. J. A., van Kampen R. J. W., Voogd A. C., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第2期

机译：在现实生活中，四分之一的激素受体阳性转移性乳腺癌患者接受化疗作为最初的姑息治疗：对东南荷兰乳腺癌协会的一项研究
2. WHICH IS MORE BENEFICIAL AS AN INITIAL THERAPY FOR THE FIRST DISTANT METASTASIS OF BREAST CANCER: CHEMOTHERAPY OR ENDOCRINE THERAPY FOR HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER PATIENTS? A SINGLE-CENTER STUDY [J] . Yamamura Jun, Shunji Kamigaki, Masaki Tsujie, The Breast : . 2015,第Suppla3期

机译：哪种更有益作为乳腺癌第一个远处转移的初始治疗：对激素受体阳性的化疗或内分泌治疗，人表皮生长因子受体2阴性乳腺癌患者？单一学习
3. Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium [J] . van Kampen R. J. W., Ramaekers B. L. T., Lobbezoo D. J. A., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：HER2阴性转移性乳腺癌患者贝伐单抗的现实世界和基于审判的成本效果分析：荷兰东南部乳腺癌联盟研究
4. Correlations between depressive symptoms and quality of life in metastatic breast cancer patients during chemotherapy [C] . Dragomir B.I., Campean A. European Association of Psychosomatic Medicine., Annual Meeting. . 2014

机译：化疗期间转移性乳腺癌患者抑郁症状与生活质量的相关性
5. Treatment Interruption and Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients [D] . Mao, Daqin . 2020

机译：激素受体阳性乳腺癌患者中的治疗中断与激素治疗中的中断和停止
6. Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium [O] . Shanly C. Seferina, Dorien J.A. Lobbezoo, Maaike de Boer, 2015

机译：曲妥珠单抗在早期乳腺癌患者中的现实生活用途和有效性：东南荷兰乳腺癌协会的一项研究
7. Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium [O] . Seferina, S.C., Lobbezoo, D.J.A., de Boer, M., 2015

机译：曲妥珠单抗在早期乳腺癌患者中的现实生活用途和有效性：东南荷兰乳腺癌协会的一项研究

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

摘要

著录项

相似文献

相关主题

期刊订阅